(ABUS) Arbutus Biopharma complete technical analysis [charts+indicators] | Buy/Sell Arbutus Biopharma | (ABUS) share price targets
Complete technical analysis of Arbutus Biopharma (ABUS) by charts plus indicators, forecast predictions and share price targets for Arbutus Biopharma (ABUS)
Arbutus Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-10-21 View latest technical analysis
10 day averaged volume of Arbutus Biopharma is 952890
| Date | Daily Closing Price | Open | High | Low | Volume |
| 21 Mon Oct 2024 | 4.07 | 4.15 | 4.15 | 3.98 | 0.827 times |
| 18 Fri Oct 2024 | 4.15 | 4.12 | 4.19 | 4.11 | 0.92 times |
| 17 Thu Oct 2024 | 4.12 | 4.20 | 4.21 | 4.08 | 0.946 times |
| 16 Wed Oct 2024 | 4.20 | 4.15 | 4.35 | 4.10 | 3.52 times |
| 15 Tue Oct 2024 | 4.11 | 3.91 | 4.12 | 3.89 | 1.232 times |
| 14 Mon Oct 2024 | 3.86 | 3.88 | 3.90 | 3.83 | 0.444 times |
| 11 Fri Oct 2024 | 3.88 | 3.79 | 3.90 | 3.79 | 0.466 times |
| 10 Thu Oct 2024 | 3.79 | 3.70 | 3.80 | 3.68 | 0.679 times |
| 09 Wed Oct 2024 | 3.76 | 3.77 | 3.78 | 3.70 | 0.693 times |
| 08 Tue Oct 2024 | 3.77 | 3.72 | 3.80 | 3.71 | 0.406 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 4.1 as stoploss in an intra day sell trade for a target of 3.92. However, stock will show a bullish move above 4.1.
Share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Target | 2.92 |
| Downside Target | 3.05 |
| Downside Target | 3.30 |
| Downside Target | 3.64 |
| Downside Target | 3.79 |
| Downside Target | 3.98 |
| Upside Target | 4.11 |
| Upside Target | 4.15 |
| Upside Target | 4.35 |
| Upside Target | 4.73 |
Intraday share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Intraday Target | 3.98 |
| Downside Intraday Target | 3.9 |
| Upside Intraday Target | 4.15 |
| Upside Intraday Target | 4.24 |
| Downside Intraday Target | 4.07 |
Weekly technical analysis of Arbutus Biopharma (ABUS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 21 Mon Oct 2024 | 4.07 | 4.15 | 4.15 | 3.98 | 0.117 times |
| 18 Fri Oct 2024 | 4.15 | 3.88 | 4.35 | 3.83 | 2.402 times |
| 11 Fri Oct 2024 | 3.88 | 3.83 | 3.90 | 3.68 | 0.672 times |
| 04 Fri Oct 2024 | 3.84 | 3.79 | 3.98 | 3.65 | 0.847 times |
| 27 Fri Sep 2024 | 3.83 | 4.05 | 4.11 | 3.79 | 0.384 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Arbutus Biopharma (ABUS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 21 Mon Oct 2024 | 4.07 | 3.81 | 4.35 | 3.65 | 0.406 times |
| 30 Mon Sep 2024 | 3.85 | 3.89 | 4.73 | 3.79 | 1.599 times |
| 30 Fri Aug 2024 | 3.87 | 3.64 | 3.95 | 3.30 | 1.02 times |
| 31 Wed Jul 2024 | 3.77 | 3.07 | 3.98 | 3.05 | 0.882 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arbutus Biopharma (ABUS)
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Arbutus Biopharma in short term and the buy signal is strong.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Arbutus Biopharma in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.06 and Arbutus Biopharma (ABUS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Arbutus Biopharma in short term and the buy signal is strong.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Arbutus Biopharma in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.06 and Arbutus Biopharma (ABUS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.